Introduction Results
Cases of persistent infection and carriers of human hepatitis viruses are known, and types B, C, and D viral hepatitis have been demonstrated in chronic liver diseases. In Japan, chronic hepatitis type B accounts for nearly 40%, type C nearly 60%, and very few cases of type D chronic hepatitis have been confirmed. Therefore, in this study we investigated the immunopathological findings of the liver and compared the mechanisms of liver injuries in type B and type C chronic hepatitis.
Material and Methods
The liver biopsy specimens were obtained from patients with chronic hepatitis B, diagnosed by the presence of hepatitis B surface antigen (HBsAg) and hepatitis B e antigen (HBeAg) in their sera, and from patients with chronic hepatitis C, diagnosed both by detection of anti-C 100 ( ΕΙΑ) and hepatitis C virus (HCV)-RNA (PCR) in their sera.
Cellular immune responses in liver tissues were observed by light and electron microscopy based on the indirect enzymelabeled antibody technique using the following monoclonal antibodies as the first antibodies and horseradish peroxidase (HRPO)-labeled rabbit-Fab' anti-mouse immunoglobins as the second antibody. For the subpopulation of lymphocytes and T cell subsets (1, 2), anti-CD8, anti-CD 11 b, anti-CD4, anti-CD22, and anti-CD57 were used as the first antibodies. Anti-ABC was used for detection of HLA-class 1 antigen (HLA-1) (3). Anti-DR, anti-DQ and anti-DP were used for HLA-class 2 antigens (ΗLΑ-2) (2). Anti-intercellular adhesion molecule-1 ('CAM-1), anti-lymphocyte function adhesion molecule-1 (LFA-1) and anti-vascular cellular adhesion molecule-1 (VCAM-1) were used for observation of adhesion molecules (4) .
For immunohistochemical detection of hepatitis B virus (HBV) related antigens in liver, anti-HBs, anti-HBc, and antiHBe were used (5, 6) . For intrahepatic HCV (2, 7), an immunohistochemical method using anti-HCV core antigen (HCcAg) and an in situ hybridization technique using Τ-Τ dimerized oligo cDNA probes were applied.
1) Chronic hepatitis, type B
At the time of onset of hepatitis or when acute exacerbation occurred, numerous CD8(+) and CDl lb(-) lymphocytes, that is cytotoxic Τ lymphocytes (CTL), were seen around the HBc(e)Ag-positive hepatocytes which had HLA-1 on the cell surface ( Fig. la, c) . A point contact or a broad contact of CTL with hepatocytes infected with HBV was often observed by immunoelectron microscopy. ICAM-1 was expressed along the surface of hepatocytes at the site of focal and piecemeal necrosis (Fig. lb) . Most mononuclear cells infiltrating into these areas were positive for LFA-1. Furthermore, immunoelectron microscopic study showed lymphocytes in contact with sinusoidal endothelial cells with surface expression of VCAM-1. HBc(e)Ag-positive hepatocytes decreased or disappeared, and the inflammation regressed in patients whose blood HBeAg decreased rapidly, DNA-polymerise became negative and liver function tests returned to normal after acute exacerbation.
2) Chronic hepatitis, type C
In the liver of patients with chronic hepatitis, type C, a follicular-like aggregation of lymphocytes and injured bile ducts in the portal areas were frequently observed. Numerous Τ lymphocytes were present immunohistochemically in the liver of patients with chronic active hepatitis, and particularly, numerous OΚΤS(+), OΚT-Ilb(-) CTL infiltrated in areas of piecemeal necrosis and focal necrosis (Fig. 2b) . In these patients, focal or diffuse distribution of liver cells presenting HLA-l was observed, whereas liver cells presenting ΗLΑ-2 were virtually not found (Fig. 2c, d) .
In most patients, HCV-RNA-or HCV-core Ag-positive liver cells were present in small numbers and sporadically (Fig.  2a) , but lobular distribution of HCV-positive hepatocytes was observed in some patients. In serial sections of a patient, liver cells presenting HLA-l on their membrane were diffusely observed in lobules containing HCV-positive liver cells, and numerous CTL were also found to infiltrate the same lobules.
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Summary Discussion
Liver cells which are positive for HBc(e)Ag are seen diffusely in the liver of healthy HBeAg-positive carriers. At the time of onset of hepatitis, a profuse infiltration by CTL is seen around the HBc(e)Ag-positive hepatic cells which have HLA-1 on the cell surface. In the recovery stage of an acute exacerbation, HBc(e)Ag-positive hepatic cells decrease rapidly and the inflammatory findings regress. These findings suggest that CTL recognizes the complexes of HLA-1 and target peptides of HBc(e)Ag cause liver cell injury. In these patients in which HLA-1 appears on the surface of hepatocytes diffusely and densely, one can frequently observe liver cells with ICAM-1 appearing on the surface, and an infiltration in their vicinity by LFA-1 positive lymphocytes. The findings further support the mechanism of liver cell damage by CTL.
Chronic hepatitis C has aspects resembling those of chronic hepatitis B on liver histograms using lymphocyte subset fractions and expression of HLA antigens. Subsequently, as a mechanism of hepatocyte injury in patients with chronic active hepatitis C, it is presumed that HCV-infected liver cell injury may be caused by CTL. However, in our observation of chronic hepatitis C, the number of HCV-infected liver cells is clearly less than that of HBV-infected liver cells in chronic hepatitis B. Furthermore, follicular-like aggregation of lymphocytes and bile duct damage, which are commonly observed in autoimmune hepatitis and primary biliary cirrhosis, are more frequently demonstrated in chronic hepatitis C than in chronic hepatitis B. These findings are intriguing in light of the correlation with autoimmune liver cell disorder, but additional studies with a larger number of cases are needed for the elucidation of other Chronic hepatitis B and chronic hepatitis C centering on immunohistochemical studies of the liver were investigated as possible mechanisms of the chronicity of viral hepatitis. Although liver cell injury was presumed to be caused by CTL in both chronic hepatitis B and C, other mechanisms of cell injury were also presumed with chronic hepatitis, type C, including autoimmune mechanisms.
